HAII corp.ltd

2:00 PM - 2:15 PM (PDT), Monday, June 13, 2022

HAII (Human AI Interaction) is developing innovative digital therapeutics in the prevention and management of mental health and disease such as dementia, depression, and grand anxiety disorders.

HAII has strived to overcome the limitations of previous medicines and drugs using ICT. We are developing software therapeutics based on peer-reviewed research without the use of any physical stimulation or drugs. This therapy does not inject medicine directly into the body and is relatively low risk compared to previous treatments.

We want to create a new path in the digital therapeutics market. Keep an eye on our future developments.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
Alztalk
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
6
Speaker
photo
CEO
HAII